A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects

NCT05232461 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: PrimeC-ER 748 mg
DRUG: Ciprofloxacin 750 MG
DRUG: Celecoxib 200mg

Sponsor

NeuroSense Therapeutics Ltd.